Doyle Mittie — Chief Medical Officer
Insider trading activity for Doyle Mittie sourced from SEC EDGAR Form 4 filings.
Overview
- Title: Chief Medical Officer
- Company: Avalo Therapeutics, Inc.
- Total insider trades: 41
- Total buy volume: $5K
- Total sell volume: $2.5M
- Last trade: Sep 1, 2026
Recent Trades
| Date | Insider | Ticker / Company | Type | Shares | Value |
|---|---|---|---|---|---|
| Aug 28, 2026 | Doyle Mittie | AVTX Avalo Therapeutics, Inc. | OTHER | 679 | N/A |
| Aug 28, 2026 | Doyle Mittie | AVTX Avalo Therapeutics, Inc. | SELL | 679 | $14K |
| Aug 28, 2026 | Doyle Mittie | AVTX Avalo Therapeutics, Inc. | OTHER | 679 | $5K |
| Aug 28, 2026 | Doyle Mittie | AAVTX Avalo Therapeutics, Inc. | BUY | 679 | $5K |
| Jun 30, 2026 | Doyle Mittie | AVTX Avalo Therapeutics, Inc. | OTHER | 1,779 | N/A |
| Jun 30, 2026 | Doyle Mittie | AVTX Avalo Therapeutics, Inc. | OTHER | 2,875 | N/A |
| Jun 30, 2026 | Doyle Mittie | AVTX Avalo Therapeutics, Inc. | SELL | 4,654 | $93K |
| Jun 30, 2026 | Doyle Mittie | AVTX Avalo Therapeutics, Inc. | OTHER | 1,779 | $14K |
| Jun 30, 2026 | Doyle Mittie | AVTX Avalo Therapeutics, Inc. | OTHER | 2,875 | $36K |
| Jun 23, 2026 | Doyle Mittie | AVTX Avalo Therapeutics, Inc. | OTHER | 1,450 | N/A |
| Jun 23, 2026 | Doyle Mittie | AVTX Avalo Therapeutics, Inc. | SELL | 1,450 | $26K |
| Jun 23, 2026 | Doyle Mittie | AVTX Avalo Therapeutics, Inc. | OTHER | 1,450 | $12K |
| Jun 16, 2026 | Doyle Mittie | CGEM Cullinan Therapeutics, Inc. | OTHER | 21,781 | N/A |
| Jun 10, 2026 | Doyle Mittie | AVTX Avalo Therapeutics, Inc. | OTHER | 1,084 | $14K |
| May 28, 2026 | Doyle Mittie | AVTX Avalo Therapeutics, Inc. | OTHER | 679 | N/A |
| May 28, 2026 | Doyle Mittie | AVTX Avalo Therapeutics, Inc. | SELL | 679 | $11K |
| May 28, 2026 | Doyle Mittie | AVTX Avalo Therapeutics, Inc. | OTHER | 679 | $5K |
| May 21, 2026 | Doyle Mittie | AVTX Avalo Therapeutics, Inc. | OTHER | 43,500 | N/A |
| May 15, 2026 | Doyle Mittie | AVTX Avalo Therapeutics, Inc. | OTHER | 3,000 | N/A |
| May 15, 2026 | Doyle Mittie | AVTX Avalo Therapeutics, Inc. | SELL | 3,000 | $56K |